Dr. Stefan Anker and Dr. C. Michael Gibson Discuss: EMPEROR-Preserved: effect of empagliflozin on cardiovascular death and heart failure hospitalizations in patients with heart failure with a preserved ejection fraction, with and without diabetes August 27, 2021 Disclosures: TBD
Dr. Burkert Pieske and Dr. C. Michael Gibson Discuss: PARALLAX: Sacubitril/Valsartan versus Individualized RAAS Blockade in Patients with HFpEF September 1, 2020
Dr. Renato Lopes and Dr. C. Michael Gibson Discuss: BRACE CORONA: Continuing vs. Suspending ACE Inhibitors and ARBs in COVID-19 September 1, 2020 Disclosures: TBD
Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss: ESC 2020 With a Focus This Year on Advances in Heart Failure and Renal Failure September 1, 2020
Dr. Roxana Mehran and Dr. C. Michael Gibson Discuss: Changes to the NSTEMI guidelines and Popular TAVI September 1, 2020
Dr. Sean Pokorney Presents: IMPACT-Afib Implementation of Stroke Prevention in Atrial Fibrillation September 1, 2020 Disclosures: TBD
Dr. Pierre-Marie Roy and Dr. C. Michael Gibson Discuss: HOME-PE – Hospitalisation or Outpatient Management of PE Patients – HESTIA vs. Simplified PESI August 31, 2020
Dr. Jan Cornel and Dr. C. Michael Gibson Discuss: LoDoCo2 Low-Dose Colchicine in Coronary Disease August 31, 2020 Disclosures: TBD
Dr. Kazem Rahimi and Dr. C. Michael Gibson Discuss: BPLTTC – Blood Pressure Lowering for Prevention of Cardiovascular Events across Different Levels of Blood Pressure August 31, 2020
